Russian cosmonauts to receive the world’s first registered vaccine against coronavirus - Sputnik V

Press release, 08.12.2020

Moscow, December 8, 2020 – The Ministry of Health of the Russian Federation, Roscosmos State Corporation, the Federal Medical and Biological Agency of Russia and the Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announce that Russian cosmonauts will be vaccinated with the world’s first registered vaccine against coronavirus - Sputnik V.

Members of the cosmonaut team and staff of The Gagarin Cosmonaut Training Center will be vaccinated with Sputnik V, named after the first artificial Earth satellite -Soviet-made Sputnik-1. 

At a later stage, other employees of the Center and key companies of Roscosmos will be able to provide their employees with the vaccine. 

Mikhail Murashko, Minister of Health of the Russian Federation, commented:

“The Sputnik V vaccine, developed by the Gamaleya National Center of the Russian Ministry of Health, will play an important role in ensuring the biological safety of Russia’s space program”.

Dmitry Rogozin, CEO of Roscosmos, noted:

“Since the beginning of the outbreak of coronavirus, Roscosmos State Corporation has pooled together all available resources to contribute to the fight against the pandemic. We have enhanced the antiviral protection system, provided employees with personal protective equipment, and are actively working with the Federal Medical and Biological Agency of Russia. Russia is now reaching a new level in the fight against COVID-19 as we begin to vaccinate the population with Sputnik V. Members of the cosmonaut team and the staff of the Cosmonaut Training Center will be among the first to be vaccinated. It is only through joint efforts that we will be able to overcome the pandemic."

Veronika Skvortsova, Head of the Federal Medical-Biological Agency, added:

“The Federal Medical and Biological Agency of Russia, alongside Roscosmos State Coproration and The Gagarin Cosmonaut Training Center, is coordinating the vaccination of members of the cosmonaut team and staff working at the center who have direct contact with cosmonauts during the training process”. 

Kirill Dmitriev, CEO of the Russian Direct Investment Fund, also commented: 

“The successful launch of the Sputnik-1 marked the beginning of the space exploration era. Decades later, the Sputnik V vaccine has become the world's first registered vaccine against coronavirus and has given hope to millions of people that the pandemic will soon be over and that life will return to normal. A cosmonaut's profession has special requirements to ensure health and safety, and the use of the Sputnik V vaccine to vaccinate employees in the space industry once again confirms its complete safety and its high efficacy in creating a long-term immunity against one of the most dangerous infections in history”. 


Russian Direct Investment Fund (RDIF) is Russia's sovereign wealth fund established in 2011 to make equity co-investments, primarily in Russia, alongside reputable international financial and strategic investors. RDIF acts as a catalyst for direct investment in the Russian economy. RDIF’s management company is based in Moscow. Currently, RDIF has experience of the successful joint implementation of more than 80 projects with foreign partners totaling more than RUB1.9 tn and covering 95% of the regions of the Russian Federation. RDIF portfolio companies employ more than 800,000 people and generate revenues which equate to more than 6% of Russia’s GDP. RDIF has established joint strategic partnerships with leading international co-investors from more than 18 countries that total more than $40 bn. Further information can be found at

For additional information contact:
Arseniy Palagin                                       Andrew Leach / Maria Shiryaevskaya
Russian Direct Investment Fund               Hudson Sandler
Press Secretary                                        Tel: +44 (0) 20 7796 4133 
Tel: +7 495 644 34 14, ext. 2395
Mobile: +7 916 110 31 41